Novo Nordisk Sues Florida Compounding Pharmacies Over Impurities In Products Claiming To Contain Wegovy Ingredient
Published
Novo Nordisk A/S NVO has reportedly taken legal action against Florida compounding pharmacies, suing one and refiling a lawsuit against another, as it discovered impurities in their products claiming to contain the active ingredient, semaglutide, for its popular weight-loss drug Wegovy. The Danish…
#novonordiskasnvo #florida #wegovy #danish #novonordisk #wellspharmacy #novo #brooksville #bpc157 #fda